Organization Profile

You just read:

Merck and Pfizer Provide Update on Phase III JAVELIN Lung 200 Trial of Avelumab Monotherapy in Previously Treated Patients with Advanced Non-Small Cell Lung Cancer

News provided by

Merck KGaA, Darmstadt, Germany

Feb 15, 2018, 08:33 ET